| Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia T Stark, J Ruda-Kucerova, FA Iannotti, C D'Addario, R Di Marco, V Pekarik, ... Neuropharmacology 146, 212-221, 2019 | 79 | 2019 |
| HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenialike animals J Večeřa, E Bártová, J Krejčí, S Legartová, D Komůrková, ... Journal of cellular physiology 233 (1), 530-548, 2018 | 76 | 2018 |
| A preliminary study of endocannabinoid system regulation in psychosis: distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia C D'Addario, V Micale, M Di Bartolomeo, T Stark, M Pucci, A Sulcova, ... Schizophrenia research 188, 132-140, 2017 | 64 | 2017 |
| Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol … M Di Bartolomeo, T Stark, OM Maurel, FA Iannotti, M Kuchar, ... Pharmacological research 164, 105357, 2021 | 57 | 2021 |
| Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment T Stark, M Di Bartolomeo, R Di Marco, E Drazanova, CBM Platania, ... Biochemical pharmacology 177, 114004, 2020 | 52 | 2020 |
| Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats E Drazanova, J Ruda-Kucerova, L Kratka, T Stark, M Kuchar, M Maryska, ... Scientific reports 9 (1), 1-10, 2019 | 37 | 2019 |
| Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats J Ruda-Kucerova, Z Babinska, P Amchova, T Stark, F Drago, A Sulcova, ... The World Journal of Biological Psychiatry 18 (2), 129-142, 2017 | 37 | 2017 |
| Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? R Androvicova, J Horacek, T Stark, F Drago, V Micale Pharmacological research 115, 200-208, 2017 | 29 | 2017 |
| Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets V Micale, M Di Bartolomeo, S Di Martino, T Stark, B Dell'Osso, F Drago, ... Pharmacology & Therapeutics 241, 108279, 2023 | 27 | 2023 |
| Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment T Stark, S Di Martino, F Drago, CT Wotjak, V Micale Pharmacological Research, 105938, 2021 | 27 | 2021 |
| Suppression of methamphetamine self-administration by ketamine pre-treatment is absent in the methylazoxymethanol (MAM) rat model of schizophrenia J Ruda-Kucerova, Z Babinska, T Stark, V Micale Neurotoxicity Research 32 (1), 121-133, 2017 | 20 | 2017 |
| Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation K Horska, H Kotolova, M Karpisek, Z Babinska, T Hammer, J Prochazka, ... Toxicology and Applied Pharmacology 406, 115214, 2020 | 14 | 2020 |
| Sex-specific and opposed effects of FKBP51 in glutamatergic and GABAergic neurons: Implications for stress susceptibility and resilience L van Doeselaar, T Stark, S Mitra, H Yang, J Bordes, L Stolwijk, ... Proceedings of the National Academy of Sciences 120 (23), e2300722120, 2023 | 11 | 2023 |
| Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia T Stark, FA Iannotti, S Di Martino, M Di Bartolomeo, J Ruda-Kucerova, ... Biomolecules 12 (1), 108, 2022 | 9 | 2022 |
| Myo-inositol levels in the dorsal hippocampus serve as glial prognostic marker of mild cognitive impairment in mice T Ebert, DE Heinz, S Almeida-Correa, R Cruz, F Dethloff, T Stark, T Bajaj, ... Frontiers in Aging Neuroscience, 751, 0 | 7 | |
| The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology M Di Bartolomeo, T Stark, S Di Martino, FA Iannotti, J Ruda-Kucerova, ... International Journal of Molecular Sciences 24 (4), 3907, 2023 | 6 | 2023 |
| Structural correlates of trauma-induced hyperarousal in mice J Ruat, DE Heinz, FP Binder, T Stark, R Neuner, A Hartmann, PM Kaplick, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 111, 110404, 2021 | 3 | 2021 |
| Prolonged QT interval in neurodevelopmental rat model of schizophrenia T Stracina, M Ronzhina, T Stark, J Ruda, E Olsanska, P Vesely, V Micale, ... 2016 Computing in Cardiology Conference (CinC), 1049-1052, 2016 | 2 | 2016 |
| Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol … M Di Bartolomeo, T Stark, OM Maurel, FA Iannotti, M Kuchar, ... Pharmacological Research 164, 105357, 2021 | 1* | 2021 |
| The effect of haloperidol administration on heart rate variability in isolated heart of schizophrenia-like and control rats O Janousek, T Stracina, M Ronzhina, J Hejc, T Stark, J Ruda, V Micale, ... 2017 Computing in Cardiology (CinC), 1-4, 2017 | 1 | 2017 |
